Use of Generic Vs Branded Drugs in Enteric Fever – A Prospective and Comparative Study

dc.contributor.authorGupta, Deveshen_US
dc.contributor.authorGupta, Arvind Kumaren_US
dc.date.accessioned2019-11-16T07:25:51Z
dc.date.available2019-11-16T07:25:51Z
dc.date.issued2017-07
dc.description.abstractBackground: The concept of generic prescription is widely accepted in various parts of the world. Nevertheless, it has failed to gain popularity in India due to factors such as non-availability and distrust on the product quality. Aim: To study cost-effective and cost-benefit analysis of antibiotic prescription in patients who had enteric fever and were given intravenous ceftriaxone.   Methods: This was a prospective observational study conducted in a tertiary care cenre at World College of Medical Science and Research, Jhajjar, Haryana. 65 patients who have been diagnosed with enteric fever and were prescribed ceftriaxone were studied and their prescriptions were analyzed. 5 brands of most commonly prescribed ceftriaxone injections were chosen to analyse cost effective and cost-benefit analysis. Results: Out of 65 patients, 40 were females and 25 were males, diagnosed with enteric fever. Maximum number of patients were seen between age group of 36-50 years (38) and minimum patients belonged to age group of more than 65 years. Analysis of prescriptions revealed that majority of the patients were prescribed Branded drugs 53 (82%) than were prescribed generic drugs 12 (18%). The analysis of the cost of single dose of inj. ceftriaxone revealed that branded drugs were 8.52 % to 180.81% more in comparison with generic IV ceftriaxone. Conclusion: The cost of most commonly prescribed branded drugs was significantly higher than generic drug and prescribing branded drugs was associated with failure to take complete treatment as prescribed by treating physician.en_US
dc.identifier.affiliationsAssistant Professor, Dept. of Pharmacology, World College of Medical Science and Research, Jhajjar, Haryana.en_US
dc.identifier.affiliationsProfessor, Dept. of Pharmacology, World College of Medical Science and Research, Jhajjar, Haryana.en_US
dc.identifier.citationGupta Devesh, Gupta Arvind Kumar. Use of Generic Vs Branded Drugs in Enteric Fever – A Prospective and Comparative Study. International Archives of BioMedical and Clinical Research. 2017 Jul-Sep; 3(3): 16-18en_US
dc.identifier.issn2454-9894
dc.identifier.issn2454-9886
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/184375
dc.languageenen_US
dc.publisherIbn Sina Academy of Medieval Medicine & Sciencesen_US
dc.relation.issuenumber3en_US
dc.relation.volume3en_US
dc.source.urihttps://doi.org/10.21276/iabcr.2017.3.3.5en_US
dc.subjectBrandeden_US
dc.subjectGenericen_US
dc.subjectenteric feveren_US
dc.subjectceftriaxoneen_US
dc.subjectRational use of medicineen_US
dc.titleUse of Generic Vs Branded Drugs in Enteric Fever – A Prospective and Comparative Studyen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
iabcr2017v3n3p16.pdf
Size:
847.49 KB
Format:
Adobe Portable Document Format